United Therapeutics President Michael Benkowitz Sells 8,800 Shares

United Therapeutics Corporation (UTHR) has announced that President and Chief Operating Officer, Michael Benkowitz, made several transactions on October 6, 2025. Specifically, he sold 800 shares at $450.97 per share, 200 shares at $253.98 per share, and 6625 shares at $452.04 per share. Additionally, he sold 11975 shares at $452.03 per share, 300 shares at $450.06 per share, 400 shares at $449.82 per share, and 1250 shares at $453.16 per share. Furthermore, he bought 14625 shares at $135.42 per share and 7875 shares at $146.03 per share. The transactions were executed on October 6, 2025.